FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
Clinical trial NCT04555811 · COMPLETED
Trial details
- NCT number
- NCT04555811
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2023-02-08
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.